InTrack Investment Management Inc Has $822,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

InTrack Investment Management Inc lowered its position in Simulations Plus, Inc. (NASDAQ:SLP) by 14.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 28,565 shares of the technology company’s stock after selling 4,978 shares during the period. InTrack Investment Management Inc’s holdings in Simulations Plus were worth $822,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of SLP. State Street Corp boosted its stake in Simulations Plus by 4.7% during the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after acquiring an additional 28,953 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock valued at $14,367,000 after purchasing an additional 18,924 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after purchasing an additional 37,992 shares in the last quarter. Tributary Capital Management LLC grew its stake in shares of Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after buying an additional 115,122 shares during the period. Finally, Royce & Associates LP increased its position in Simulations Plus by 28.8% in the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after buying an additional 53,092 shares in the last quarter. 78.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. BTIG Research reduced their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. KeyCorp decreased their price target on shares of Simulations Plus from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Finally, Stephens started coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $49.00.

Simulations Plus Stock Performance

Shares of SLP stock opened at $29.92 on Friday. The company has a market capitalization of $601.09 million, a price-to-earnings ratio of 74.80 and a beta of 0.80. Simulations Plus, Inc. has a 52-week low of $24.00 and a 52-week high of $51.22. The company has a 50-day simple moving average of $29.80 and a two-hundred day simple moving average of $33.19.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.18 earnings per share. On average, sell-side analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the completion of the sale, the director now owns 3,442,584 shares in the company, valued at $109,336,467.84. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.